[1]ómez-Puerta A J ,Cervera R . Diagnosis and classification of the antiphospholipid syndrome[J]. Journal of Autoimmunity,2014,48-49.[2]Islam MA, Alam F, Gan SH,et al. A ,et al. 15-year single centre retrospective study of antiphospholipid syndrome patients from Northern Malaysia. Malays J Pathol. 2017;39(2):123-133.[3]Tektonidou MG, Andreoli L, Limper M, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis. 2019;78(10):1296-1304.[4]Ruffatti A, Favaro M, Calligaro A,et al. Management of pregnant women with antiphospholipid antibodies. Expert Rev Clin Immunol. 2019;15(4):347-358.[5]Ruiz-Irastorza G, Crowther M, Branch W, et al. Antiphospholipid syndrome. Lancet. 2010;376(9751):1498-1509.[6]赵久良,沈海丽,柴克霞等.抗磷脂综合征诊疗规范[J].中华内科杂志,2022,61(09):1000-1007[7]产科抗磷脂综合征诊断与处理专家共识[J].中华围产医学杂志,2020,23(08):517-522.[8]Chaturvedi S, Braunstein EM, Brodsky RA. Antiphospholipid syndrome: Complement activation, complement gene mutations, and therapeutic implications. J Thromb Haemost. 2021;19(3):607-616.[9]Gelaye B, Barrios YV, Zhong QY, et al. Association of poor subjective sleep quality with suicidal ideation among pregnant Peruvian women. Gen Hosp Psychiatry. 2015;37(5):441-447.[10]Mellor R, Chua SC, Boyce P. Antenatal depression: an artefact of sleep disturbance?. Arch Womens Ment Health. 2014;17(4):291-302.[11]Irwin MR, Olmstead R, Carroll JE. Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation. Biol Psychiatry. 2016;80(1):40-52.[12]Irwin MR. Sleep and inflammation: partners in sickness and in health. Nat Rev Immunol. 2019;19(11):702-715.[13]Beihl DA, Liese AD, Haffner SM. Sleep duration as a risk factor for incident type 2 diabetes in a multiethnic cohort. Ann Epidemiol. 2009;19(5):351-357.[14]Nahum Sacks K, Friger M, Shoham-Vardi I, et al. Prenatal exposure to gestational diabetes mellitus as an independent risk factor for long-term neuropsychiatric morbidity of the offspring. Am J Obstet Gynecol. 2016;215(3):380.e1-380.e3807.[15]Svensson T, Saito E, Svensson AK, et al. Association of Sleep Duration With All- and Major-Cause Mortality Among Adults in Japan, China, Singapore, and Korea. JAMA Netw Open. 2021;4(9):e2122837. Published 2021 Sep 1.[16]Mindell JA, Cook RA, Nikolovski J. Sleep patterns and sleep disturbances across pregnancy. Sleep Med. 2015;16(4):483-488.[17]Kızılırmak A, Timur S, Kartal B. Insomnia in pregnancy and factors related to insomnia. ScientificWorldJournal. 2012;2012:197093.[18]Nodine PM, Matthews EE. Common sleep disorders: management strategies and pregnancy outcomes. J Midwifery Womens Health. 2013;58(4):368-377.[19]Clinton JM, Davis CJ, Zielinski MR, et al. Biochemical regulation of sleep and sleep biomarkers. J Clin Sleep Med. 2011;7(5 Suppl):S38-S42.[20]Chiu YL, Chuang YF, Fang KC, et al. Higher systemic inflammation is associated with poorer sleep quality in stable haemodialysis patients. Nephrol Dial Transplant. 2009;24(1):247-251.[21]Weinberger JF, Raison CL, Rye DB, et al. Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation. Brain Behav Immun. 2015;47:193-200.[22]Ferrie JE, Kivimäki M, Akbaraly TN, et al. Associations between change in sleep duration and inflammation: findings on C-reactive protein and interleukin 6 in the Whitehall II Study. Am J Epidemiol. 2013;178(6):956-961.[23]Yin J, Gong R, Zhang M, et al. Associations between sleep disturbance, inflammatory markers and depressive symptoms: Mediation analyses in a large NHANES community sample. Prog Neuropsychopharmacol Biol Psychiatry. 2023;126:110786.[24]Davis CJ, Krueger JM. Sleep and Cytokines. Sleep Med Clin. 2012;7(3):517-527.[25]Lacourt TE, Vichaya EG, Chiu GS, et al . The High Costs of Low-Grade Inflammation: Persistent Fatigue as a Consequence of Reduced Cellular-Energy Availability and Non-adaptive Energy Expenditure. Front Behav Neurosci. 2018;12:78. Published 2018 Apr 26.[26]Atkins C, Wilson AM. Managing fatigue in sarcoidosis - A systematic review of the evidence. Chron Respir Dis. 2017;14(2):161-173.[27]Salvi V, Gianello V, Tiberio L, et al. Cytokine Targeting by miRNAs in Autoimmune Diseases. Front Immunol. 2019;10:15. Published 2019 Jan 29.[28]Kuwabara T, Ishikawa F, Kondo M, et al. The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases. Mediators Inflamm. 2017;2017:3908061.[29]Zielinski MR, McKenna JT, McCarley RW. Functions and Mechanisms of Sleep. AIMS Neurosci. 2016;3(1):67-104.[30]Al-Diwani A, Handel A, Townsend L, et al. The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data. Lancet Psychiatry. 2019;6(3):235-246.[31]Braley TJ, Segal BM, Chervin RD. Obstructive sleep apnea and fatigue in patients with multiple sclerosis. J Clin Sleep Med. 2014;10(2):155-162. Published 2014 Feb 15.[32]Ning P, Hu F, Yang B, et al. Systematic review and meta-analysis of observational studies to understand the prevalence of restless legs syndrome in multiple sclerosis: an update. Sleep Med. 2018;50:97-104.[33]Högl B, Heidbreder A, Santamaria J, et al. IgLON5 autoimmunity and abnormal behaviours during sleep. Lancet. 2015;385(9977):1590.[34]Silber MH. Autoimmune sleep disorders. Handb Clin Neurol. 2016;133:317-326.[35]Katz Sand I. Neuromyelitis Optica Spectrum Disorders. Continuum (Minneap Minn). 2016;22(3):864-896.[36]Song Y, Pan L, Fu Y, et al. Sleep abnormality in neuromyelitis optica spectrum disorder. Neurol Neuroimmunol Neuroinflamm. 2015;2(3):e94. Published 2015 Apr 16.[37]Karkare K, Sinha S, Taly AB, Rao S. Prevalence and profile of sleep disturbances in Guillain-Barre Syndrome: a prospective questionnaire-based study during 10 days of hospitalization. Acta Neurol Scand. 2013;127(2):116-123.[38]Bahnasy WS, El-Heneedy YAE, El-Shamy AM, et al. Sleep and psychiatric abnormalities in Gullian Barré Syndrome. Egypt J Neurol Psychiatr Neurosurg. 2018;54(1):5.[39]Gao J, Li Y, Sun Y, et al. The study of sleep disorder factors in patients with Guillain-Barré syndrome. Int J Neurosci. 2016;126(10):893-898[40]Irani SR, Pettingill P, Kleopa KA, et al. Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol. 2012;72(2):241-255.[41]Abou-Zeid E, Boursoulian LJ, Metzer WS, Gundogdu B. Morvan syndrome: a case report and review of the literature. J Clin Neuromuscul Dis. 2012;13(4):214-227.[42]中华医学会神经病学分会睡眠障碍学组.中国发作性睡病诊断与治疗指南(2022 版)[J].中华神经科杂志,2022,55(05):406-420.[43]Gaig C, Graus F, Compta Y, et al. Clinical manifestations of the anti-IgLON5 disease. Neurology. 2017;88(18):1736-1743.[44]Knaack L, Janicki J. Rheumatologische Erkrankungen und Schlaf –Schlafmedizinische Aspekte der Diagnostik und Therapie – Eine literaturbasierte Übersicht [Rheumatological Diseases and Sleep: Somnological Aspects of Diagnostics and Therapy]. Laryngorhinootologie. 2019;98(11):776-788.[45]Opp MR. Cytokines and sleep. Sleep Med Rev. 2005;9(5):355-364.[46]Chandrasekhara PK, Jayachandran NV, Rajasekhar L, et al. The prevalence and associations of sleep disturbances in patients with systemic lupus erythematosus. Mod Rheumatol. 2009;19(4):407-415.[47]Vina ER, Green SL, Trivedi T, et al. Correlates of sleep abnormalities in systemic lupus: a cross-sectional survey in an urban, academic center. J Clin Rheumatol. 2013;19(1):7-13.[48]Grabovac I, Haider S, Berner C, et al. Sleep Quality in Patients with Rheumatoid Arthritis and Associations with Pain, Disability, Disease Duration, and Activity. J Clin Med. 2018;7(10):336. Published 2018 Oct 9.[49]Chung WS, Lin CL. Sleep disorders associated with risk of rheumatoid arthritis. Sleep Breath. 2018;22(4):1083-1091.[50]Taylor-Gjevre RM, Gjevre JA, Skomro R, et al. Restless legs syndrome in a rheumatoid arthritis patient cohort. J Clin Rheumatol. 2009;15(1):12-15.[51]Chung SW, Hur J, Ha YJ, et al. Impact of sleep quality on clinical features of primary Sjögren's syndrome. Korean J Intern Med. 2019;34(5):1154-1164.[52]Priori R, Minniti A, Antonazzo B, et al. Sleep quality in patients with primary Sjögren's syndrome. Clin Exp Rheumatol. 2016;34(3):373-379.[53]Segal BM, Pogatchnik B, Henn L, et al. Pain severity and neuropathic pain symptoms in primary Sjögren's syndrome: a comparison study of seropositive and seronegative Sjögren's syndrome patients. Arthritis Care Res (Hoboken). 2013;65(8):1291-1298.[54]de Oliveira LV, Sinicato NA, Appenzeller S, et al. Sleep disorders in primary antiphospholipid syndrome. Clin Rheumatol. 2018;37(12):3345-3349
